Do we use methylation of NFATC1 and FOS genes as a biomarker for postmenopausal osteoporosis?

by Kalkan R, Tosun O
Published 2021-03-01

RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause

by Kalkan R, Altarda M, Tosun O
Published 2020-08-01

Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma

by Ikbal Atli E, Gurkan H, Onur Kirkizlar H, Atli E, Demir S, Yalcintepe S, Kalkan R, Demir AM
Published 2021-03-01